Sign Up to like & get
recommendations!
1
Published in 2021 at "Molecular and cellular biochemistry"
DOI: 10.1007/s11010-021-04233-y
Abstract: Pancreatic cancer is considered as one of the most aggressive tumor types, representing over 45,750 mortality cases annually in the USA solely. The aggressive nature and late identification of pancreatic cancer, combined with the restrictions…
read more here.
Keywords:
therapy pancreatic;
micrornas biomarkers;
biomarkers perspectives;
pancreatic cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Photodiagnosis and photodynamic therapy"
DOI: 10.1016/j.pdpdt.2020.101876
Abstract: Photodynamic therapy (PDT) is a potential adjuvant therapy in pancreatic cancer with several advantages. Mechanistically, pancreatic cancer PDT can induce apoptosis and necrosis of pancreatic cancer cells and lead to vascular damage and enhance anti-tumor…
read more here.
Keywords:
therapy pancreatic;
photodynamic therapy;
pancreatic cancer;
pdt ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancers"
DOI: 10.3390/cancers10040103
Abstract: Mortality from pancreatic ductal adenocarcinoma (PDAC) has remained essentially unchanged for decades and its relative contribution to overall cancer death is projected to only increase in the coming years. Current treatment for PDAC includes aggressive…
read more here.
Keywords:
therapy pancreatic;
gene therapy;
role gene;
review ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24043559
Abstract: Pancreatic cancer is an aggressive malignancy with high mortality rates and poor prognoses. Despite rapid progress in the diagnosis and treatment of pancreatic cancer, the efficacy of current therapeutic strategies remains limited. Hence, better alternative…
read more here.
Keywords:
mesenchymal stromal;
pancreatic cancer;
stromal cell;
therapy pancreatic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v28.i25.2881
Abstract: Incretin-based therapies like glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help maintain the glycaemic control in patients with type 2 diabetes mellitus with additional systemic benefits and little risk of hypoglycaemia. These medications are…
read more here.
Keywords:
incretin based;
based therapy;
pancreatic cancer;
cancer realising ... See more keywords